Lilly - TechWire

Lilly

2025.06.12

16:52

Eli Lilly's multi-dose prefilled pen for telportolide injection is launched in China

Eli Lilly announced that on June 12, 2025, Mufengda (multi-dose prefilled pen for telportolide injection) was launched in China. This is a new injection device launched by Eli Lilly after the successful launch of telportolide at the beginning of the year to increase supply in China and meet the needs of more patients.

2025.06.04

11:16

Eli Lilly and Camurus reach agreement to jointly develop drugs for obesity and diabetes

Eli Lilly has signed a licensing and development agreement with Camurus, under which the two parties will jointly develop long-acting insulinotropic drugs for the treatment of obesity, diabetes and other metabolic diseases based on Camurus' FluidCrystal technology. The agreement allows Eli Lilly to develop up to four proprietary drug compounds, including GIP/GLP-1 receptor agonists, GIP/glucagon/GLP-1 receptor agonists, and options including amylin receptor agonists. At the same time, according to the agreement, Camurus is eligible for potential development and sales milestone payments of up to $870 million and mid-single-digit royalties.

2025.05.16

19:21

Eli Lilly (LLY.N) rose 1.8% in premarket trading after the chief executive of rival Novo Nordisk (NVO.N) resigned.

2025.05.12

22:53

Eli Lilly (LLY.N) shares rose 1.3 percent to an intraday high.

21:58

Novo Nordisk fell nearly 2%. Eli Lilly said Zepbound's weight loss effect is much better than Wegovy

Novo Nordisk fell nearly 2% to $64.5. On the news front, Eli Lilly announced that its weight loss drug Zepbound performed better than Novo Nordisk Wegovy in five weight loss goals in a comparative trial.

21:31

U.S. stocks open higher as trade talks boost sentiment

The three major U.S. stock indexes opened sharply higher, with the Dow Jones Industrial Average up 2.6%, the S&P 500 up nearly 3%, and the Nasdaq up 4%. Apple rose 5.8% as it was reported that it was considering raising the price of its new iPhone in the fall. Tesla rose 6.9% and Nvidia rose 5.1%. Pharmaceutical stocks narrowed their losses at the opening, with Eli Lilly down 0.9% and Novo Nordisk down 2.4%.

21:14

Eli Lilly (LLY.N) rose sharply after falling more than 5% earlier, while Novo Nordisk (NVO.N) narrowed its pre-market decline to 1.1%.

21:12

US pharmaceutical stocks collectively rose, Eli Lilly turned positive before the market opened

U.S. pharmaceutical stocks rose collectively, with Eli Lilly turning positive before the market opened, while Novo Nordisk fell about 1% after previously falling more than 6%.

20:56

20:53

Eli Lilly's stock price fell 4.8% in pre-market trading

Eli Lilly's stock price fell 4.8% in pre-market trading.

07:34

Eli Lilly announces detailed results of head-to-head study: Telpotide is superior to semaglutide in reducing weight and waist circumference

On May 12, Eli Lilly announced detailed results from the SURMOUNT-5 study. The study is an open-label Phase 3b clinical trial designed to evaluate the efficacy and safety of the GLP/GLP-1 dual receptor agonist tirzepatide and the GLP-1 single receptor agonist semaglutide in overweight adults (without diabetes) who are obese or have at least one comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). At week 72, tirzepatide achieved the primary endpoint and all five key secondary endpoints, and showed superiority over semaglutide throughout the trial.

2025.05.07

04:12

The three major U.S. stock indexes closed down collectively, with pharmaceutical stocks leading the decline

The three major U.S. stock indexes closed down collectively, with the Dow Jones Industrial Average down 0.95%, the Nasdaq down 0.87%, and the S&P 500 down 0.77%. Most large technology stocks fell, with Meta down more than 2%, Tesla and Intel down more than 1%, Apple, Microsoft, Google, and Amazon down slightly; Netflix rose slightly. Pharmaceutical stocks fell the most, with Sarepta Therapeutics Inc (SRPT) down more than 26% and Eli Lilly down more than 5%. Palantir fell more than 12%, the worst single-day performance in a year. Nuclear power concept stock Constellation Energy Corp. (CEG) rose more than 10%, the largest single-day gain since February 21.

2025.05.02

07:08

The three major U.S. stock indexes closed higher, with the S&P 500 and Dow Jones both recording eight consecutive daily gains

The three major U.S. stock indexes closed higher, with the Nasdaq up 1.52%, the S&P 500 up 0.63%, and the Dow up 0.21%. Among them, the S&P 500 and the Dow both recorded eight consecutive daily gains. Microsoft surged more than 7%, and the company's third quarter of fiscal year 2025 exceeded expectations across the board, with strong growth in cloud computing business. Meta rose more than 4%, Amazon rose more than 3%, Nvidia rose more than 2%, Google rose more than 1%, Apple and Netflix rose slightly; Tesla and Intel fell slightly. Eli Lilly fell more than 11%, the largest single-day drop since 2008.

2025.05.01

22:13

Eli Lilly (LLY.N) executives: The current tariff measures have not had a substantial impact on the company's financial outlook for 2025. The expansion of tariffs in other regions or the increase in retaliatory tariffs will have a negative impact on the industry.

18:46

Eli Lilly (LLY.N) reiterated its revenue guidance.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Air India flight returns after takeoff due to technical issues
                            2025-06-16

                                    Southbound funds made a large net purchase of 5.743 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), China Construction Bank and Meituan-W received net purchases of HK$1.108 billion and HK$493 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$1.489 billion; in terms of Hong Kong Stock Connect (Shenzhen), Meituan-W and Kangfang Biopharma received net purchases of HK$622 million and HK$206 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$391 million.
                            2025-06-16

                                    Arm (ARM.O): We are better than Nvidia on a wider range of platforms.
                            2025-06-12

                                    Lei Jun: Xiaomi Yu7 will be released at the end of June
                            2025-06-16

                                    Putin: Russia will create unmanned system forces as a separate branch of the military
                            2025-06-13